# US 2013/0252968 A1 · Alkyl amides as hiv attachment inhibitors

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0252968 A1
- Document ID: US20130252968A1
- Status: Published application
- Kind: A1
- Application number: 13/990,815
- Filed: 2011-12-01
- Published: 2013-09-26
- Earliest claimed: 2010-12-02
- Assignees: Bristol-Myers Squibb Company
- Inventors: Tao Wang; Zhongxing Zhang; Zhiwei Yin; John F. Kadow; Nicholas A. Meanwell
- Web page: https://patentgrep.com/patent/US20130252968A1

## CPC

- C07D 471/04: Ortho-condensed systems
- A61P 31/18: for HIV
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Compounds of Formula (I), including pharmaceutically acceptable salts thereof, wherein A is selected from the group (II), are useful as HIV attachment inhibitors.

## Claims

### Claim 1

A compound of Formula I, including pharmaceutically acceptable salts thereof:
wherein A is selected from the group consisting of:
wherein
a, b, c, d and e are independently selected from the group consisting of hydrogen, halogen, cyano, nitro, COOR56, XR57, NA1A2, C(O)R7, C(O)NR55R56, B, Q, and E;
B is selected from the group consisting of —C(═NR46)(R47), C(O)NR40R41, aryl, heteroaryl, heteroalicyclic, S(O)2R8, C(O)R7, XR8a, (C1-6)alkylNR40R41,
(C1-6)alkylCOOR8b; wherein said aryl, heteroaryl, and heteroalicyclic are optionally substituted with one to three same or different halogens or from one to three same or different substituents selected from the group F; wherein aryl is napthyl or substituted phenyl; wherein heteroaryl is a mono or bicyclic system which contains from 3 to 7 ring atoms for a mono cyclic system and up to 12 atoms in a fused bicyclic system, including from 1 to 4 heteroatoms; wherein heteroalicyclic is a 3 to 7 membered mono cyclic ring which may contain from 1 to 2 heteroatoms in the ring skeleton and which may be fused to a benzene or pyridine ring;
Q is selected from the group consisting of (C1-6)alkyl and (C2-6)alkenyl; wherein said (C1-6)alkyl and (C2-6)alkenyl are optionally substituted with one to three same or different halogens or from one to three same or different substituents selected from the group consisting of C(O)NR55R56, hydroxy, cyano and XR57;
E is selected from the group consisting of (C1-6)alkyl and (C2-6)alkenyl; wherein said (C1-6)alkyl and (C2-6)alkenyl are independently optionally substituted with a member selected from the group consisting of phenyl, heteroaryl, SMe, SPh,
—C(O)NR56R57, C(O)R57, SO2(C1-6)alkyl and SO2Ph; wherein heteroaryl is a monocyclic system which contains from 3 to 7 ring atoms, including from 1 to 4 heteroatoms;
R7 is selected from the group consisting of aryl, heteroaryl, and heteroalicyclic; wherein said aryl, heteroaryl, and heteroalicyclic are optionally substituted with one to three same or different halogens or with from one to three same or different substituents selected from the group F;
wherein for R7, R8, R8a, R8b aryl is phenyl; heteroaryl is a mono or bicyclic system which contains from 3 to 7 ring atoms for mono cyclic systems and up to 10 atoms in a bicyclic system, including from 1 to 4 heteroatoms; wherein heteroalicyclic is selected from the group consisting of aziridine, azetidine, pyrrolidine, piperazine, piperidine, tetrahydrofuran, tetrahydropyran, azepine, and morpholine;
F is selected from the group consisting of (C1-6)alkyl, (C3-7)cycloalkyl, aryl, heteroaryl, heteroalicyclic, hydroxy, (C1-6)alkoxy, aryloxy, (C1-6)thioalkoxy, cyano, halogen, nitro, —C(O)R57, benzyl, —NR42C(O)—(C1-6)alkyl, —NR42C(O)—(C3-6)cycloalkyl, —NR42C(O)-aryl, —NR42C(O)-heteroaryl, —NR42C(O)-heteroalicyclic, a 4, 5, or 6 membered ring cyclic N-lactam, —NR42S(O)2—(C1-6)alkyl, —NR42S(O)2—(C3-6)cycloalkyl, —NR42S(O)2-aryl, —NR42S(O)2-heteroaryl, —NR42S(O)2-heteroalicyclic, S(O)2(C1-6)alkyl, S(O)2aryl, —S(O)2 NR42R43, NR42R43, (C1-6)alkylC(O)NR42R43, C(O)NR42R43, NHC(O)NR42R43, OC(O)NR42R43, NHC(O)OR54, (C1-6)alkylNR42R43, COOR54, and (C1-6)alkylCOOR54; wherein said (C1-6)alkyl, (C3-7)cycloalkyl, aryl, heteroaryl, heteroalicyclic, (C1-6)alkoxy, and aryloxy, are optionally substituted with one to nine same or different halogens or from one to five same or different substituents selected from the group G; wherein aryl is phenyl; heteroaryl is a monocyclic system which contains from 3 to 7 ring atoms, including from 1 to 4 heteroatoms; heteroalicyclic is selected from the group consisting of aziridine, azetidine, pyrrolidine, piperazine, piperidine, tetrahydrofuran, tetrahydropyran, azepine, and morpholine;
R8 is selected from the group consisting of hydrogen, (C1-6)alkyl, (C3-7)cycloalkyl, (C2-6)alkenyl, (C3-7)cycloalkenyl, (C2-6)alkynyl, aryl, heteroaryl, and heteroalicyclic; wherein said (C1-6)alkyl, (C3-7)cycloalkyl, (C2-6)alkenyl, (C3-7)cycloalkenyl, (C2-6)alkynyl, aryl, heteroaryl, and heteroalicyclic are optionally substituted with one to six same or different halogens or from one to five same or different substituents selected from the group F or (C1-6)alkyl, (C3-6)cycloalkyl, cyano, phenyl, aryl, heteroaryl, heteroalicyclic, hydroxy, (C1-6)alkoxy, halogen, benzyl, primary amine, secondary amine, tertiary amine, ammonium, nitro, thiol, thioether, alcohol, ether, acid, aldehyde, ketone, amide, amidine, guanidine, sulfone, sulfonamide, sulfamide, acyl sulfamide, sulfate, sulfuric acid, sulfamic acid, phosphate, phosphoric acid, boronic ester, boronic acid, squarate, squaric acid, oxime, hydrazine, peroxide, among which ether, peroxide, thioether, secondary amine, tertiary amine, ammonium, ester, ketone, amide, amidine, oxime, hydrazine can be either acyclic or cyclic; heteroaryl is selected from the group consisting of furanyl, thienyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, imidazolyl, oxadiazolyl, thiadiazolyl, pyrazolyl, tetrazolyl, triazolyl, pyridinyl, pyrazinyl, pyridazinyl, and pyrimidinyl;
R8a is a member selected from the group consisting of aryl, heteroaryl, and heteroalicyclic; wherein each member is independently optionally substituted with one to six same or different halogens or from one to five same or different substituents selected from the group F;
R8b is selected from the group consisting of hydrogen, (C1-6)alkyl and phenyl;
X is selected from the group consisting of NH or NCH3, O, and S;
R40 and R41 are independently selected from the group consisting of
(a) hydrogen; (b) (C1-6)alkyl or (C3-7)cycloalkyl substituted with one to three same or different halogens or from one to two same or different substituents selected from the group F or different functional groups: (C1-6)alkyl, (C3-6)cycloalkyl, cyano, phenyl, aryl, heteroaryl, heteroalicyclic, hydroxy, (C1-6)alkoxy, halogen, benzyl, primary amine, secondary amine, tertiary amine, ammonium, nitro, thiol, thioether, alcohol, ether, acid, aldehyde, ketone, amide, amidine, guanidine, sulfone, sulfonamide, sulfamide, acyl sulfamide, sulfate, sulfuric acid, sulfamic acid, phosphate, phosphoric acid, boronic ester, boronic acid, squarate, squaric acid, oxime, hydrazine, peroxide, among which ether, peroxide, thioether, secondary amine, tertiary amine, ammonium, ester, ketone, amide, amidine, oxime, hydrazine can be either acyclic or cyclic; heteroaryl is selected from the group consisting of furanyl, thienyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, imidazolyl, oxadiazolyl, thiadiazolyl, pyrazolyl, tetrazolyl, triazolyl, pyridinyl, pyrazinyl, pyridazinyl, and pyrimidinyl; and (c) (C1-6)alkoxy, aryl, heteroaryl or heteroalicyclic; or R40 and R41 taken together with the nitrogen to which they are attached form a member selected from the group consisting of aziridine, azetidine, pyrrolidine, piperazine, 4—NMe piperazine, piperidine, azepine, and morpholine; and wherein said aryl, heteroaryl, and heteroalicyclic are optionally substituted with one to three same or different halogens or from one to two same or different substituents selected from the group F; wherein for R40 and R41 aryl is phenyl; heteroaryl is a monocyclic system which contains from 3 to 6 ring atoms, including from 1 to 4 heteroatoms; heteroalicyclic is selected from the group consisting of aziridine, azetidine, pyrrolidine, piperazine, piperidine, tetrahydrofuran, tetrahydropyran, azepine, and morpholine; provided when B is C(O)NR40R41, at least one of R40 and R41 is not selected from groups (a) or (b);
R42 and R43 are independently selected from the group consisting of hydrogen, (C1-6)alkyl, allyl, (C1-6)alkoxy, (C3-7)cycloalkyl, aryl, heteroaryl and heteroalicyclic; or R42 and R43 taken together with the nitrogen to which they are attached form a member selected from the group consisting of aziridine, azetidine, pyrrolidine, piperazine, 4—NMe piperazine, piperidine, azepine, and morpholine; and wherein said (C1-6)alkyl, (C1-6)alkoxy, (C3-7)cycloalkyl, aryl, heteroaryl, and heteroalicyclic are optionally substituted with one to three same or different halogens or from one to two same or different substituents selected from the group G or different functional groups: (C1-6)alkyl, (C3-6)cycloalkyl, cyano, phenyl, aryl, heteroaryl, heteroalicyclic, hydroxy, (C1-6)alkoxy, halogen, benzyl, primary amine, secondary amine, tertiary amine, ammonium, nitro, thiol, thioether, alcohol, ether, acid, aldehyde, ketone, amide, amidine, guanidine, sulfone, sulfonamide, sulfamide, acyl sulfamide, sulfate, sulfuric acid, sulfamic acid, phosphate, phosphoric acid, boronic ester, boronic acid, squarate, squaric acid, oxime, hydrazine, peroxide, among which ether, peroxide, thioether, secondary amine, tertiary amine, ammonium, ester, ketone, amide, amidine, oxime, hydrazine can be either acyclic or cyclic; heteroaryl is selected from the group consisting of furanyl, thienyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, imidazolyl, oxadiazolyl, thiadiazolyl, pyrazolyl, tetrazolyl, triazolyl, pyridinyl, pyrazinyl, pyridazinyl, and pyrimidinyl; wherein for R42 and R43 aryl is phenyl; heteroaryl is a monocyclic system which contains from 3 to 6 ring atoms, including from 1 to 4 heteroatoms; heteroalicyclic is a member selected from the group consisting of aziridine, azetidine, pyrrolidine, piperazine, piperidine, tetrahydrofuran, tetrahydropyran, azepine, and morpholine;
G is selected from the group consisting of (C1-6)alkyl, (C3-7)cycloalkyl, aryl, heteroaryl, heteroalicyclic, hydroxy, (C1-6)alkoxy, aryloxy, cyano, halogen, nitro, —C(O)R57, benzyl, —NR48C(O)—(C1-6)alkyl, —NR48C(O)—(C3-6)cycloalkyl, —NR48C(O)-aryl, —NR48C(O)-heteroaryl, —NR48C(O)-heteroalicyclic, a 4, 5, or 6 membered ring cyclic N-lactam, —NR48S(O)2—(C1-6)alkyl, —NR48S(O)2—(C3-6)cycloalkyl, —NR48S(O)2-aryl, —NR48S(O)2-heteroaryl, —NR48S(O)2-heteroalicyclic, sulfinyl, sulfonyl, sulfonamide, NR48R49, (C1-6)alkyl C(O)NR48R49, C(O)NR48R49, NHC(O)NR48R49, OC(O)NR48R49, NHC(O)OR54′, (C1-6)alkylNR48R49, COOR54, and (C1-6)alkylCOOR54; wherein aryl is phenyl; heteroaryl is a monocyclic system which contains from 3 to 7 ring atoms, including from 1 to 4 heteroatoms; heteroalicyclic is selected from the group consisting of aziridine, azetidine, pyrrolidine, piperazine, piperidine, tetrahydrofuran, tetrahydropyran, azepine, and morpholine;
R46 is selected from the group consisting of H, OR57, and NR55R56;
R47 is selected from the group consisting of H, amino, halogen, phenyl, aryl, heteroaryl and (C1-6)alkyl;
R48 and R49 are independently selected from the group consisting of hydrogen, (C1-6)alkyl, phenyl, aryl and heteroaryl;
R50 is selected from the group consisting of H, (C1-6)alkyl, (C3-6)cycloalkyl, and benzyl; wherein each of said (C1-6)alkyl, (C3-7)cycloalkyl and benzyl are optionally substituted with one to three same or different (C1-6)alkyl, (C3-6)cycloalkyl, cyano, phenyl, aryl, heteroaryl, heteroalicyclic, hydroxy, (C1-6)alkoxy, halogen, benzyl, primary amine, secondary amine, tertiary amine, ammonium, nitro, thiol, thioether, alcohol, ether, acid, aldehyde, ketone, amide, amidine, guanidine, sulfone, sulfonamide, sulfamide, acyl sulfamide, sulfate, sulfuric acid, sulfamic acid, phosphate, phosphoric acid, boronic ester, boronic acid, squarate, squaric acid, oxime, hydrazine, peroxide, among which ether, peroxide, thioether, secondary amine, tertiary amine, ammonium, ester, ketone, amide, amidine, oxime, hydrazine can be either acyclic or cyclic; heteroaryl is selected from the group consisting of furanyl, thienyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, imidazolyl, oxadiazolyl, thiadiazolyl, pyrazolyl, tetrazolyl, triazolyl, pyridinyl, pyrazinyl, pyridazinyl, and pyrimidinyl
R54 is selected from the group consisting of hydrogen and (C1-6)alkyl;
R54′ is (C1-6)alkyl;
R55 and R56 are independently selected from the group consisting of hydrogen and (C1-6)alkyl; and
R57 is selected from the group consisting of hydrogen, (C1-6)alkyl, aryl, heteroaryl; and
A1 and A2 are independently selected from hydrogen, (C1-6)alkyl, aryl, heteroaryl, SO2D1, SO2ND2D3, COD4, COCOD4, COOD4, COND5D6, COCOND5D6, COCOOD4, C(═ND7)D8, C(═ND9)ND10D11;
A1 and A2 can either never connect with each other, or conjoin to form a ring structure;
D1, D2, D3, D4, D5, D6, D7, D8, D9, D10, and D11 are each independently selected from the group consisting of H, C1-C50 alkyl, C3-C50 cycloalkyl, C3-C50 alkenyl, C4-C50 cycloalkenyl, phenyl, heteroaryl, C3-C50 amide and C3-C50 ether; heteroaryl is selected from the group consisting of pyridinyl, pyrazinyl, pyridazinyl, pyrimidinyl, furanyl, thienyl, benzothienyl, thiazolyl, isothiazolyl, oxazolyl, benzooxazolyl, isoxazolyl, imidazolyl, benzoimidazolyl, 1H-imidazo[4,5-b]pyridin-2-yl, 1H-imidazo[4,5-c]pyridin-2-yl, oxadiazolyl, thiadiazolyl, pyrazolyl, tetrazolyl, tetrazinyl, triazinyl and triazolyl; provided the carbon atoms which comprise the carbon-carbon double bond of said C3-C20 alkenyl or the carbon-carbon triple bond of said C3-C20 alkynyl are not the point of attachment to the nitrogen to which D2, D3, D5, D6, D7, D9, D10, and D11 is attached; wherein said C1-C50 alkyl, C3-C50 cycloalkyl, C3-C50 alkenyl, C4-C50 cycloalkenyl, aryl, phenyl, heteroaryl, C3-C50 amide and C3-C50 ether is optionally substituted with one to three same or different of the following functionalities: (C1-6)alkyl, (C3-6)cycloalkyl, cyano, phenyl, aryl, heteroaryl, heteroalicyclic, hydroxy, (C1-6)alkoxy, halogen, benzyl, primary amine, secondary amine, tertiary amine, ammonium, nitro, thiol, thioether, alcohol, ether, acid, aldehyde, ketone, amide, amidine, guanidine, sulfone, sulfonamide, sulfamide, acyl sulfamide, sulfate, sulfuric acid, sulfamic acid, phosphate, phosphoric acid, boronic ester, boronic acid, squarate, squaric acid, oxime, hydrazine, peroxide, among which ether, peroxide, thioether, secondary amine, tertiary amine, ammonium, ester, ketone, amide, amidine, oxime, hydrazine can be either acyclic or cyclic;
I1, I2, I3, I4, I5, I6, I7 and I8 are each independently selected from the group consisting of H, (C1-6)alkyl, (C3-6) cycloalkyl, (C2-6) alkenyl, (C4-6) cycloalkenyl, (C2-6) alkynyl, CR81R82OR83, COR84, COOR85, or CONR86R87; wherein each of said alkyl and cycloalkyl being optionally substituted with one to three same or different cyano, phenyl, aryl, heteroaryl, heteroalicyclic, hydroxy, (C1-6)alkoxy, halogen, benzyl, primary amine, secondary amine, tertiary amine, ammonium, nitro, thiol, thioether, alcohol, ether, acid, aldehyde, ketone, amide, amidine, guanidine, sulfone, sulfonamide, sulfamide, acyl sulfamide, sulfate, sulfuric acid, sulfamic acid, phosphate, phosphoric acid, boronic ester, boronic acid, squarate, squaric acid, oxime, hydrazine, peroxide, among which ether, peroxide, thioether, secondary amine, tertiary amine, ammonium, ester, ketone, amide, amidine, oxime, hydrazine can be either acyclic or cyclic; heteroaryl is selected from the group consisting of furanyl, thienyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, imidazolyl, oxadiazolyl, thiadiazolyl, pyrazolyl, tetrazolyl, triazolyl, pyridinyl, pyrazinyl, pyridazinyl, and pyrimidinyl;
J is selected from the group consisting of H, C1-C30 alkyl, C3-C15 cycloalkyl, C4-C30 bicycloalkyl, C5-C30 tricycloalkyl, C6-C30 tetracycloalkyl, C3-C30 alkenyl, C4-C30 cycloalkenyl, C5-C30 bicycloalkenyl, C7-C30 tricycloalkenyl, C9-C30 tetracycloalkyl, C1-C30 amide, C3-C30 cyclic amide, C1-C30 amine, C3-C30 cyclic amine, C2-C30 ester, C3-C30 cyclic ester, C2-C30 ether, C3-C30 cyclic ether, C1-C30 sulfonamide, C3-C30 cyclic sulfonamide, C2-C30 sulfone, C3-C30 cyclic sulfone, C2-C30 urea, and C3-C30 cyclic urea; wherein said C1-C30 alkyl, C3-C30 cycloalkyl, C4-C30 bicycloalkyl, C5-C30 tricycloalkyl, C6-C30 tetracycloalkyl, C3-C30 alkenyl, C4-C30 cycloalkenyl, C5-C30 bicycloalkenyl, C7-C30 tricycloalkenyl, C9-C30 tetracycloalkyl, C1-C30 amide, C3-C30 cyclic amide, C1-C30 amine, C3-C30 cyclic amine, C2-C30 ester, C3-C30 cyclic ester, C2-C30 ether, C3-C30 cyclic ether, C1-C30 sulfonamide, C3-C30 cyclic sulfonamide, C2-C30 sulfone, C3-C30 cyclic sulfone, C2-C30 urea, and C3-C30 cyclic urea is optionally substituted with one to three same or different of the following functionalities: (C1-6)alkyl, (C3-6)cycloalkyl, cyano, phenyl, aryl, heteroaryl, heteroalicyclic, hydroxy, (C1-6)alkoxy, halogen, benzyl, primary amine, secondary amine, tertiary amine, ammonium, nitro, thiol, thioether, alcohol, ether, acid, aldehyde, ketone, amide, amidine, guanidine, sulfone, sulfonamide, sulfamide, acyl sulfamide, sulfate, sulfuric acid, sulfamic acid, phosphate, phosphoric acid, boronic ester, boronic acid, squarate, squaric acid, oxime, hydrazine, peroxide, among which ether, peroxide, thioether, secondary amine, tertiary amine, ammonium, ester, ketone, amide, amidine, oxime, hydrazine can be either acyclic or cyclic; and
R81, R82, R83, R84, R85, R86, and R87 are each independently selected from the group consisting of H, (C1-6)alkyl, (C3-6) cycloalkyl, (C2-6) alkenyl, (C4-6) cycloalkenyl, and (C2-6) alkynyl.

### Claim 2 (depends on 1)

The compound as claimed in claim 1, wherein one of a, b, c, d, and e is selected from group B or group E.

### Claim 3 (depends on 1)

The compound as claimed in claim 1, wherein B is selected from the group consisting of C(O)NR40R41, aryl, heteroaryl, and XR8a.

### Claim 4 (depends on 1)

The compound as claimed in claim 1, wherein Q is (C1-6)alkyl.

### Claim 5 (depends on 1)

The compound as claimed in claim 1, wherein E is (C2-6)alkenyl; optionally substituted with a member selected from the group consisting of phenyl, heteroaryl, —C(O)NR56R57, and C(O)R57.

### Claim 6 (depends on 1)

The compound as claimed in claim 1, wherein R7 is selected from the group of phenyl, pyridinyl, pyrazinyl, pyridazinyl, pyrimidinyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, imidazolyl, oxadiazolyl, thiadiazolyl, pyrazolyl, tetrazolyl, triazinyl and triazolyl; wherein said phenyl, pyridinyl, pyrazinyl, pyridazinyl, pyrimidinyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, imidazolyl, oxadiazolyl, thiadiazolyl, pyrazolyl, tetrazolyl, triazinyl and triazolyl are optionally substituted with one to three same or different halogens or with from one to three same or different substituents selected from the group F.

### Claim 7 (depends on 1)

The compound as claimed in claim 1, wherein F is selected from the group consisting of (C1-6)alkyl, (C3-7)cycloalkyl, hydroxy, (C1-6)alkoxy, cyano, halogen, —NR42C(O)—(C1-6)alkyl, —NR42C(O)—(C3-6)cycloalkyl, a 4, 5, or 6 membered ring cyclic N-lactam, —NR42S(O)2—(C1-6)alkyl, —NR42S(O)2—(C3-6)cycloalkyl, S(O)2(C1-6)alkyl, —S(O)2 NR42R43, NR42R43, (C1-6)alkylC(O)NR42R43, C(O)NR42R43, NHC(O)NR42R43, OC(O)NR42R43, NHC(O)OR54, (C1-6)alkylNR42R43, COOR54, and (C1-6)alkylCOOR54.

### Claim 8 (depends on 1)

The compound as claimed in claim 1, wherein X is NH, NCH3, or O.

### Claim 9 (depends on 1)

The compound as claimed in claim 1, wherein R40 and R41 are selected from the group of (a) hydrogen; (b) (C1-6)alkyl or (C3-7)cycloalkyl substituted with one to three same or different halogens or from one to two same or different substituents selected from the group F or different functional groups: (C1-6)alkyl, (C3-6)cycloalkyl, phenyl, aryl, heteroaryl, heteroalicyclic, hydroxy, (C1-6)alkoxy, halogen, primary amine, secondary amine, tertiary amine, ammonium, alcohol, ether, acid, ketone, amide, amidine, guanidine, sulfone, sulfonamide, sulfamide, acyl sulfamide, sulfate, sulfuric acid, sulfamic acid, phosphate, phosphoric acid, boronic ester, boronic acid, squarate, squaric acid, oxime, hydrazine, among which ether, secondary amine, tertiary amine, ammonium, ester, ketone, amide, amidine, oxime, hydrazine can be either acyclic or cyclic; heteroaryl is selected from the group consisting of thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, imidazolyl, oxadiazolyl, thiadiazolyl, pyrazolyl, tetrazolyl, triazolyl, pyridinyl, pyrazinyl, pyridazinyl, and pyrimidinyl; and (c) (C1-6)alkoxy, aryl, heteroaryl or heteroalicyclic; or R40 and R41 taken together with the nitrogen to which they are attached form a member selected from the group consisting of azetidine, pyrrolidine, piperazine, 4—NMe piperazine, piperidine, azepine, and morpholine; and wherein said aryl, heteroaryl, and heteroalicyclic are optionally substituted with one to three same or different halogens or from one to two same or different substituents selected from the group F; wherein for R40 and R41 aryl is phenyl; heteroaryl is a monocyclic system which contains from 3 to 6 ring atoms, including from 1 to 4 heteroatoms; heteroalicyclic is selected from the group consisting of azetidine, pyrrolidine, piperazine, piperidine, tetrahydrofuran, tetrahydropyran, azepine, and morpholine; provided when B is C(O)NR40R41, at least one of R40 and R41 is not selected from groups (a) or (b).

### Claim 10 (depends on 1)

The compound as claimed in claim 1, wherein R42 and R43 are selected from the group of hydrogen, (C1-6)alkyl, a (C1-6)alkoxy, (C3-7)cycloalkyl, aryl, heteroaryl and heteroalicyclic; or R42 and R43 taken together with the nitrogen to which they are attached form a member selected from the group consisting of azetidine, pyrrolidine, piperazine, 4—NMe piperazine, piperidine, azepine, and morpholine; and wherein said (C1-6)alkyl, (C1-6)alkoxy, (C3-7)cycloalkyl, aryl, heteroaryl, and heteroalicyclic are optionally substituted with one to three same or different halogens or from one to two same or different substituents selected from the group G or different functional groups: (C1-6)alkyl, (C3-6)cycloalkyl, phenyl, aryl, heteroaryl, heteroalicyclic, hydroxy, (C1-6)alkoxy, halogen, benzyl, primary amine, secondary amine, tertiary amine, ammonium, alcohol, ether, acid, ketone, amide, amidine, guanidine, sulfone, sulfonamide, sulfamide, acyl sulfamide, sulfate, sulfuric acid, sulfamic acid, phosphate, phosphoric acid, boronic ester, boronic acid, squarate, squaric acid, oxime, hydrazine, among which ether, secondary amine, tertiary amine, ammonium, ester, ketone, amide, amidine, oxime, hydrazine can be either acyclic or cyclic; heteroaryl is selected from the group consisting of thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, imidazolyl, oxadiazolyl, thiadiazolyl, pyrazolyl, tetrazolyl, triazolyl, pyridinyl, pyrazinyl, pyridazinyl, and pyrimidinyl; wherein for R42 and R43 aryl is phenyl; heteroaryl is a monocyclic system which contains from 3 to 6 ring atoms, including from 1 to 4 heteroatoms; heteroalicyclic is a member selected from the group consisting of azetidine, pyrrolidine, piperazine, piperidine, tetrahydrofuran, tetrahydropyran, azepine, and morpholine.

### Claim 11 (depends on 1)

The compound as claimed in claim 1, wherein G is selected from the group consisting of (C1-6)alkyl, (C3-7)cycloalkyl, hydroxy, (C1-6)alkoxy, cyano, halogen, —NR42C(O)—(C1-6)alkyl, —NR42C(O)—(C3-6)cycloalkyl, a 4, 5, or 6 membered ring cyclic N-lactam, —NR42S(O)2—(C1-6)alkyl, —NR42S(O)2—(C3-6)cycloalkyl, S(O)2(C1-6)alkyl, —S(O)2 NR42R43, NR42R43, (C1-6)alkylC(O)NR42R43, C(O)NR42R43, NHC(O)NR42R43, OC(O)NR42R43, NHC(O)OR54, (C1-6)alkylNR42R43, COOR54, and (C1-6)alkylCOOR54.

### Claim 12 (depends on 1)

The compound as claimed in claim 1, wherein A1 and A2 are selected from the group consisting of hydrogen, (C1-6)alkyl, aryl, heteroaryl, COD4, COCOD4, COOD4, COND5D6, COCOND5D6, and COCOOD4.

### Claim 13 (depends on 1)

The compound as claimed in claim 1, wherein D4, D5, and D6 are selected from the group consisting of H, C1-C10 alkyl, C3-C10 cycloalkyl, C3-C10 alkenyl, C4-C10 cycloalkenyl, phenyl, heteroaryl, C3-C10 amide and C3-C10 ether; heteroaryl is selected from the group consisting of pyridinyl, pyrazinyl, pyridazinyl, pyrimidinyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, imidazolyl, oxadiazolyl, thiadiazolyl, pyrazolyl, tetrazolyl, triazinyl and triazolyl; provided the carbon atoms which comprise the carbon-carbon double bond of said C3-C10 alkenyl or the carbon-carbon triple bond of said C3-C10 alkynyl are not the point of attachment to the nitrogen to which D5 and D6 is attached; wherein said C1-C10 alkyl, C3-C10 cycloalkyl, C3-C10 alkenyl, C4-C10 cycloalkenyl, aryl, phenyl, heteroaryl, C3-C10 amide and C3-C10 ether is optionally substituted with one to three same or different of the following functionalities: (C1-6)alkyl, (C3-6)cycloalkyl, cyano, phenyl, aryl, heteroaryl, heteroalicyclic, hydroxy, (C1-6)alkoxy, halogen, primary amine, secondary amine, tertiary amine, ammonium, alcohol, ether, acid, ketone, amide, amidine, guanidine, sulfone, sulfonamide, sulfamide, acyl sulfamide, sulfate, sulfuric acid, sulfamic acid, phosphate, phosphoric acid, boronic ester, boronic acid, squarate, squaric acid, oxime, hydrazine, peroxide, among which ether, thioether, secondary amine, tertiary amine, ammonium, ester, ketone, amide, amidine, oxime, hydrazine can be either acyclic or cyclic.

### Claim 14 (depends on 1)

The compound as claimed in claim 1, wherein I1, I2, I3, I4, I5, I6, I7 and I8 are selected from the group of H, (C1-6)alkyl, (C3-6) cycloalkyl, (C2-6) alkenyl, CR81R82OR83, COR84, COOR85, and CONR86R87.

### Claim 15 (depends on 1)

The compound as claimed in claim 1, wherein J is selected from the group consisting of H, C1-C10 alkyl, C3-C10 cycloalkyl, C4-C15 bicycloalkyl, C5-C20 tricycloalkyl, C6-C25 tetracycloalkyl, C3-C10 alkenyl, C4-C10 cycloalkenyl, C5-C15 bicycloalkenyl, C7-C20 tricycloalkenyl, C9-C25 tetracycloalkyl, C1-C10 amide, C3-C10 cyclic amide, C1-C10 amine, C3-C10 cyclic amine, C2-C10 ester, C3-C10 cyclic ester, C2-C10 ether, C3-C10 cyclic ether, C1-C10 sulfonamide, C3-C10 cyclic sulfonamide, C2-C10 sulfone, C3-C10 cyclic sulfone, C2-C10 urea, and C3-C10 cyclic urea; wherein said H, C1-C10 alkyl, C3-C10 cycloalkyl, C4-C15 bicycloalkyl, C5-C20 tricycloalkyl, C6-C25 tetracycloalkyl, C3-C10 alkenyl, C4-C10 cycloalkenyl, C5-C15 bicycloalkenyl, C7-C20 tricycloalkenyl, C9-C25 tetracycloalkyl, C1-C10 amide, C3-C10 cyclic amide, C1-C10 amine, C3-C10 cyclic amine, C2-C10 ester, C3-C10 cyclic ester, C2-C10 ether, C3-C10 cyclic ether, C1-C10 sulfonamide, C3-C10 cyclic sulfonamide, C2-C10 sulfone, C3-C10 cyclic sulfone, C2-C10 urea, and C3-C10 cyclic urea is optionally substituted with one to three same or different of the following functionalities: (C1-6)alkyl, (C3-6)cycloalkyl, cyano, phenyl, aryl, heteroaryl, heteroalicyclic, hydroxy, (C1-6)alkoxy, halogen, primary amine, secondary amine, tertiary amine, ammonium, alcohol, ether, acid, ketone, amide, amidine, guanidine, sulfone, sulfonamide, sulfamide, acyl sulfamide, sulfate, phosphate, squarate, oxime, among which ether, secondary amine, tertiary amine, ammonium, ester, ketone, amide, amidine, oxime, can be either acyclic or cyclic.

### Claim 16 (depends on 1)

The compound as claimed in claim 1, wherein R81, R82, R83, R84, R85, R86, and R87 are selected from the group consisting of H, (C1-6)alkyl and (C3-6) cycloalkyl.

### Claim 17

A compound which is selected from the group of:

### Claim 18 (depends on 1)

A pharmaceutical composition which comprises an antiviral effective amount of one or more of the compounds of Formula I as claimed in claim 1, together with one or more pharmaceutically acceptable carriers, excipients or diluents.

### Claim 19 (depends on 17)

A pharmaceutical composition which comprises an antiviral effective amount of one or more of the compounds of Formula I as claimed in claim 17, together with one or more pharmaceutically acceptable carriers, excipients or diluents.

### Claim 20 (depends on 1)

A method for treating a mammal infected with HIV comprising administering to said mammal an antiviral effective amount of a compound of Formula I as claimed in claim 1, and one or more pharmaceutically acceptable carriers, excipients or diluents.

### Claim 21 (depends on 17)

A method for treating a mammal infected with HIV comprising administering to said mammal an antiviral effective amount of a compound of Formula I as claimed in claim 17, and one or more pharmaceutically acceptable carriers, excipients or diluents.
